Related Articles
Changes in serum thymidine kinase 1 levels during chemotherapy correlate with objective response in patients with advanced gastric cancer
Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical response and organ/function preservation.
CISPLATIN PLUS VP16 AS SALVAGE TREATMENT FOR ADVANCED BREAST-CARCINOMA RESISTANT OR RECURRENT AFTER 1ST LINE CHEMOTHERAPY FOR METASTATIC DISEASE
Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine‑refractory pancreatic cancer patients
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: A phase II study with organ-sparing purposes